Equicord
Us
Veterinary Advanced Therapies
We are national leaders in advanced veterinary therapies
EquiCord was born in 2012 in the hands of a multidisciplinary team formed up of veterinarians, biologists, engineers and pharmacists.
After positioning ourselves as national leaders in advanced veterinary therapies, we decided to take the leap into the European pharmaceutical industry by conducting various safety / efficacy clinical trials and building pioneering GMP facilities in the veterinary biotechnology sector.
After years of research, in 2019 we received the first European license for a drug based on Equine Umbilical Cord Mesenchymal Stem Cells (EUC-MSCs): HorStem®
Following the success of HorStem®, in 2022 EquiCord received unanimous marketing authorisation for DogStem®: the world's first stem cell-based medicine for the treatment of canine osteoarthritis.
Our Mission
At EquiCord we seek the development of new drugs that improve the quality of life of patients without ever forgetting to apply the maximum scientific rigor to our developments.
Our technology
EquiCord has developed a manufacturing process that allows obtaining high quality cells from a tissue such as the equine umbilical cord, which allows obtaining cells in a non-invasive way, prioriticing animal welfare.
Obtaining umbilical cord cells represents a competitive advantage over other sources of stem cells; with a younger starting material, greater proliferation capacity and greater safety compared to other sources such as adipose tissue, bone marrow or peripheral blood.
Our Facilities
EquiCord’s laboratories have been specifically designed for the manufacture of HorStem® and DogStem®, seeking the optimisation of industrial processes and the highest quality of our products. Moreover, we also have a quality control laboratory in our own facilities that allow us to carry out the quality controls following the highest European standards.
Team
Iñigo Lusarreta
ilusarreta@equicord.com
Industrial Engineer. Extensive experience in industrial companies.
Almudena Pradera
apradera@equicord.com
Doctor in Veterinary Medicine (DVM), Masters in Research and Development of medicines, PhD in physiology & pharmacology.
Miguel Rico
María García
mgarcia@equicord.com
Bachelor degree in Biology, Masters in Cell Therapies Targets MCs.
Eva Punzón
epunzon@equicord.com
Bachelor degree in Biology & Masters in Pharmacological Research.
Carlos García-Navas
cgarcia@equicord.com
Bachelor degree in Pharmacists, Masters in pharma industry.
Marisol Muñoz
Iñigo Lusarreta
Chief Executive Officerilusarreta@equicord.com
Industrial Engineer. Deep experience in industrial companies
Almudena Pradera
Chief Scientific Officer & Business Development
apradera@equicord.com
Doctor in Veterinary Medicine (DVM), Masters in Research and Development of medicines, PhD in physiology & pharmacology.
María García
Production Manager & Regulatory Affairs Associate
mgarcia@equicord.com
Bachelor degree in Biology, Masters in Cell Therapies Targets MCs.
Carlos García-Navas
Qualified Person & Quality Assurances
cgarcia@equicord.com
Bachelor degree in Pharmacists, Masters in pharma industry.
Eva Punzón
Clinical Research Associatedepunzon@equicord.com
Bachelor degree in Biology & Masters in Pharmacological Research
